Nuclear Associates of Carle Place, NY, has begun marketing a digitalmammography phantom that makes it easier to compare the imagequality of digital and conventional mammography biopsy systems.Due to the phantom's small size (6.7 x 6.4 cm, with a 4-cm
Nuclear Associates of Carle Place, NY, has begun marketing a digitalmammography phantom that makes it easier to compare the imagequality of digital and conventional mammography biopsy systems.Due to the phantom's small size (6.7 x 6.4 cm, with a 4-cm thickness),it can be imaged in its entirety in a single exposure, avoidingthe need to move the phantom. The phantom also contains the sameobjects that are embedded in the Mammographic Accreditation Phantom,according to the company.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.